ASSERTIO
Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise (gabapentin) tablets for the manage... ment of Postherpetic Neuralgia (PHN), Cambia (diclofenac potassium for oral solution) for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor (diclofenac potassium) liquid-filled capsules for relief of mild to moderate acute pain, and Lazanda (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.
ASSERTIO
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Pharmaceutical
Founded:
1995-01-01
Address:
Lake Forest, Illinois, United States
Country:
United States
Website Url:
http://www.assertiotx.com
Total Employee:
101+
Status:
Active
Contact:
224.419.7106
Email Addresses:
[email protected]
Total Funding:
1.01 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Font API Google Tag Manager WordPress Google Analytics Google Maps Content Delivery Network
Similar Organizations
Agilent Technologies
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
Alixia
Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Peplin
Peplin is a specialty pharmaceutical company focused on advancing and commercializing medical dermatology products.
Sumitomo Pharma America Holdings
Sumitomo Pharma America Holdings supports and enables the discovery, development, and commercialization of treatments to help patients.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-04-25 | Spectrum Pharmaceuticals | Spectrum Pharmaceuticals acquired by Assertio | N/A |
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - Assertio
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Assertio
Morgan Stanley
Morgan Stanley investment in Post-IPO Debt - Assertio
RBC Capital Markets
RBC Capital Markets investment in Post-IPO Debt - Assertio
Thomas Weisel Partners
Thomas Weisel Partners investment in Post-IPO Equity - Assertio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-01-17 | LGS Foundation | Assertio investment in Grant - LGS Foundation | 100 K USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-29 | Assertio names Brendan OโGrady as its new CEO |
| 2023-03-06 | Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical |
Official Site Inspections
http://www.assertiotx.com Semrush global rank: 2.94 M Semrush visits lastest month: 5.4 K
- Host name: 148.148.38.73
- IP address: 148.148.38.73
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Assertio"
Assertio Holdings » Compliance & Ethics
Assertio Holdings, Inc. - Governance - Governance Documents
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»
Assertio Holdings » Assertioโs Action Plan
For our company, these truly are exciting times, however the start of our organization comes at a time of incredible turmoil in our country. While weโve been navigating the impact of Covid-19 โฆSee details»
Assertio - Overview, News & Similar companies | ZoomInfo.com
Feb 17, 2021 Assertio has announced that a new Chief Commercial Officer has joined the organization. Executive Moves, New Hire ... 419-7106 Website: www.assertiotx.com What โฆSee details»
Assertio Holdings, Inc. - Investor Relations
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»
Assertio Announces Restructuring Plan and Leadership Changes
Dec 15, 2020 To learn more about Assertio, visit www.assertiotx.com.Investor Contact Lee Roth Burns McClellan for Assertio Holdings, Inc. [email protected] [email protected] โฆSee details»
Assertio Company Profile | Management and Employees List
SQL International Organization for Standardization . CSS World Wide Web Consortium . Network Hardware (4 Technologies) Cisco Nexus Cisco . Cisco Hardware Cisco . ...See details»
Assertio Company Profile - Office Locations, Competitors, Revenue ...
Oct 29, 2024 Assertio has 5 employees at their 1 location and $152.07 m in annual revenue in FY 2023. See insights on Assertio including office locations, competitors, revenue, financials, โฆSee details»
Assertio Holdings Inc. - Cruelty Free Investing
Company Website: https://www.assertiotx.com Contact: [email protected] ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization โฆSee details»
Assertio Holdings » Overview
Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001See details»
Assertio Holdings » Management
Ms. Dir joined Assertio in August 2023 as Vice President, Human Resources and has served as Vice President, Human Resources, IT and Facilities since November 2023. In her current role, โฆSee details»
Assertio Holdings, Inc. - Governance - Committee Composition
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»
Assertio Holdings, Inc. (Assertio Holdings, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธด โฆ
To learn more about Assertio, visit www.assertiotx.com. Forward Looking Statements Statements in this communication that are not historical facts are forward-looking statements that reflect โฆSee details»
Assertio Holdings » CORPORATE RESPONSIBILITY STATEMENT
Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001See details»
Assertio Holdings, Inc. - Resources - Investor Contacts
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»
Assertio Holdings, Inc. - Financials - SEC Filings
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»
Garantex Cryptocurrency Exchange Disrupted in International โฆ
Mar 7, 2025 Garantex Splash Page. In conjunction with the operation targeting Garantex, the Department also announced the unsealing of an indictment in the Eastern District of Virginia โฆSee details»
Assertio Holdings » Board of Directors
Mr. OโGrady, age 57, most recently served as CEO of the Global Formulations Business at Glenmark Pharmaceuticals Ltd. (India: NSE), a multinational pharmaceutical company, from โฆSee details»
Assertio Holdings, Inc. - Financials - Annual Reports
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»
Assertio Holdings, Inc. - Events & Presentations
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your โฆSee details»